Genomic signature and mutation trend analysis of pandemic (H1N1) 2009 influenza A virus

PLoS ONE

Volumn 5, Issue 3, 2010, Pages

  Pan, Chungen ^a,b   Cheung, Byron ^a   Tan, Suiyi ^a,c   Li, Chunling ^d   Li, N ^a,c   Liu, Shuwen ^c   Jiang, Shibo ^c  

^a NEW YORK BLOOD CENTER   (United States)

^b PEKING UNIVERSITY   (China)

^c SOUTHERN MEDICAL UNIVERSITY   (China)

^d INSTITUTE OF ANIMAL SCIENCE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ISOLEUCINE; VALINE;

AMINO ACID SEQUENCE; ARTICLE; CONTROLLED STUDY; GENE MUTATION; HOST RANGE; INFLUENZA VIRUS A H1N1; MOLECULAR DYNAMICS; NONHUMAN; PANDEMIC; PROTEIN SECONDARY STRUCTURE; SEQUENCE ANALYSIS; VIRAL GENETICS; VIRUS GENOME; VIRUS MUTATION; VIRUS VIRULENCE; ANIMAL; AVIAN INFLUENZA; BIRD; GENETICS; HUMAN; HUMAN GENOME; INFLUENZA; MUTATION; NUCLEOTIDE SEQUENCE; PROTEIN TERTIARY STRUCTURE; SWINE; VIRULENCE;

INFLUENZA A VIRUS; SUIDAE;

ANIMALS; BIRDS; DNA MUTATIONAL ANALYSIS; GENOME, HUMAN; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA IN BIRDS; INFLUENZA, HUMAN; MUTATION; PANDEMICS; PROTEIN STRUCTURE, TERTIARY; SWINE; VIRULENCE;

EID: 77949678181     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0009549     Document Type: Article

References (31)

1. CDC (2009) Swine influenza A (H1N1) infection in two children - Southern California, March-April 2009. MMWR 58: 402.
2. Smith GJD, Vijaykrishna D, Bahl J, Lycett SJ, Worobey M, et al. (2009) Origins and evolutionary genomics of the 2009 swine-origin H1N1 influenza A epidemic. Nature 459: 1122-1125.
3. Itoh Y, Shinya K, Kiso M, Watanabe T, Sakoda Y, et al. (2009) In vitro and in vivo characterization of new swine-origin H1N1 influenza viruses. Nature 460: 1021-1025.
4. Garten RJ, Davis CT, Russell CA, Shu B, Lindstrom S, et al. (2009) Antigenic and genetic characteristics of swine-origin 2009 A(H1N1) influenza viruses circulating in humans. Science 325: 197-201.
5. Miller MA, Viboud C, Balinska M, Simonsen L (2009) The signature features of influenza pandemics-implications for policy. N Engl J Med 360: 2595-2598.
6. Chen GW, Chang SC, Mok CK, Lo YL, Kung YN, et al. (2006) Genomic signatures of human versus avian influenza A viruses. Emerg Infect Dis 12: 1353-1360.
7. Chen GW, Shih SR. Genomic Signatures of Influenza A Pandemic (H1N1) 2009. Virus. Emerg. Infect. Dis 15: 1897-1903.
8. Vana G, Westover KM (2008) Origin of the 1918 Spanish influenza virus: a comparative genomic analysis. Mol Phylogenet Evol 47: 1100-1110.
9. Cutler J, Schleihauf E, Hatchette TF, Billard B, Watson-Creed G, et al. (2009) Investigation of the first cases of human-to-human infection with the new swine-origin influenza A (H1N1) virus in Canada. CMAJ 181: 159-163.
10. Fisman DN, Savage R, Gubbay J, Achonu C, Akwar H, et al. (2009) Older age and a reduced likelihood of 2009 H1N1 virus infection. N Engl J Med 361: 2000-2001.
11. Hancock K, Veguilla V, Lu X, Zhong W, Butler EN, et al. (2009) Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus. N Engl J Med 361: 1945-1952.
12. Naffakh N, Tomoiu A, Rameix-Welti MA, van der WS (2008) Host restriction of avian influenza viruses at the level of the ribonucleoproteins. Annu Rev Microbiol 62: 403-424.
13. Ye Q, Krug RM, Tao YJ (2006) The mechanism by which influenza A virus nucleoprotein forms oligomers and binds RNA. Nature 444: 1078-1082.
14. Biswas SK, Boutz PL, Nayak DP (1998) Influenza virus nucleoprotein interacts with influenza virus polymerase proteins. J Virol 72: 5493-5501.
15. Gabriel G, Dauber B, Wolff T, Planz O, Klenk HD, et al. (2005) The viral polymerase mediates adaptation of an avian influenza virus to a mammalian host. Proc Natl Acad Sci USA 102: 18590-18595.
16. Collins PJ, Haire LF, Lin YP, Liu J, Russell RJ, et al. (2008) Crystal structures of oseltamivir-resistant influenza virus neuraminidase mutants. Nature 453: 1258-1261.
17. Kim CU, Lew W, Williams MA, Liu H, Zhang L, et al. (1997) Influenza neuraminidase inhibitors possessing a novel hydrophobic interaction in the enzyme active site: design, synthesis, and structural analysis of carbocyclic sialic acid analogues with potent anti-influenza activity. J Am Chem Soc 119: 681-690.
18. von IM,Wu WY, Kok GB, Pegg MS, Dyason JC, et al. (1993) Rational design of potent sialidase-based inhibitors of influenza virus replication. Nature 363: 418-423.
19. Gubareva LV, Kaiser L, Matrosovich MN, Soo-Hoo Y, Hayden FG (2001) Selection of influenza virus mutants in experimentally infected volunteers treated with oseltamivir. J Infect Dis 183: 523-531.
20. Chen H, Cheung CL, Tai H, Zhao P, Chan JF, et al. (2009) Oseltamivir-resistant influenza A pandemic (H1N1) 2009 virus, Hong Kong, China. Emerg Infect Dis 15: 1970-1972.
21. Baz M, Abed Y, Papenburg J, Bouhy X, Hamelin ME, et al. (2009) Emergence of Oseltamivir-resistant pandemic H1N1 virus during prophylaxis. N Engl J Med 361: 2296-2297.
22. Gamblin SJ, Haire LF, Russell RJ, Stevens DJ, Xiao B, et al. (2004) The structure and receptor binding properties of the 1918 influenza hemagglutinin. Science 303: 1838-1842.
23. Rogers GN, Paulson JC (1983) Receptor determinants of human and animal influenza virus isolates: differences in receptor specificity of the H3 hemagglutinin based on species of origin. Virology 127: 361-373.
24. Bornholdt ZA, Prasad BV (2008) X-ray structure of NS1 from a highly pathogenic H5N1 influenza virus. Nature 456: 985-988.
25. Talon J, Horvath CM, Polley R, Basler CF, Muster T, et al. (2000) Activation of Interferon Regulatory Factor 3 Is Inhibited by the Influenza A Virus NS1 Protein. The Journal of Virology 74: 7989-7996.
26. Wang X, Li M, Zheng H, Muster T, Palese P, et al. (2000) Influenza A Virus NS1 Protein Prevents Activation of NF-kappa B and Induction of Alpha/Beta Interferon. The Journal of Virology 74: 11566-11573.
27. Seo SH, Hoffmann E, Webster RG (2002) Lethal H5N1 influenza viruses escape host anti-viral cytokine responses. Nat Med 8: 950-954.
28. Ye Q, Krug RM, Tao YJ (2006) The mechanism by which influenza A virus nucleoprotein forms oligomers binds RNA. Nature 444: 1078-1082.
29. Biswas SK, Boutz PL, Nayak DP (1998) Influenza virus nucleoprotein interacts with influenza virus polymerase proteins. J Virol 72: 5493-5501.
30. Pan C, Wang G, Liao M, Zhang GH, Jiang S (2009) High genetic and antigenic similarity between a swine H3N2 influenza A virus and a prior human influenza vaccine virus: A possible immune pressure-driven cross-species transmission. Biochem Biophys Res Commun 385: 402-407.
31. Delano WL. The PyMOL molecular graphics system (http://www.pymol.org). 005. DeLano Scientific LLC. 400, Oyster Point Blvd., Suite 213, South San Francisco, CA 94080-1918 USA.